|
|||||
|
|
KEYNOTE-032: A Randomized Phase I Study of Pembrolizumab in Chinese Patients with Advanced Non-Small Cell Lung Cancer |
|
| Authors: | Yuxiang Ma Wenfeng Fang Yang Zhang Yunpeng Yang Shaodong Hong Yuanyuan Zhao Shuang Xie Jun Ge HaoJin Zhou Hongyun Zhao Li Zhang |
| Affiliation: | 1. Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, People's Republic of China;2. MSD China, Beijing, People's Republic of China;3. MSD China, Shanghai, People's Republic of China |
| Abstract: | |
| Keywords: | |